Skip to main content
. 2018 Jan 9;9(10):9021–9029. doi: 10.18632/oncotarget.24078

Figure 4.

Figure 4

(A) HEK293T(VEGFR2+) target cell killing by VEGFR2-specific FnCAR-YT cells or YT cells transduced with an irrelevant Fn3(CEA)CAR, at the indicated E:T ratios. (B) IFNgamma release by FnCAR-transduced or non-transduced YT cells in the presence (black bars) or absence (grey bars) of target HEK(VEGFR2+) cells. kCEA-28z CAR targeting an irrelevant surface molecule, CEA, was used as a negative control.